Marketingstepup

"It will manufacture the vaccine in the country against influenza A ((BELOW WILL HAVE THE PROOF OF WHY THIS IS NOT AS POSITIVE AS CREATE)) The Argentina will produce the vaccine against influenza A (H1N1), announced President Cristina Fernandez de Kirchner at the inauguration of the International Symposium on Stem Cell Research at the Fundaci n Instituto Leloir. The vaccine is manufactured through an agreement between domestic and foreign laboratories, with technical and logistical support of the state.Therefore, the President signed a decree to decl plowing the "national interest" and enable the implementation of production, starting in 2010. Last winter, the influenza epidemic in Argentina, killing 600 people, according to the latest report by the Ministry of Health of the Nation, and affected more than 1,200,000 people. In the First World countries, where the virus has entered back into circulation with the arrival of the cold, the vaccine was developed in record time, and it began to be applied in countries like the United States. Health Minister's Office, Juan Manzur, welcomed the news yesterday inaugurated publicly in Mar del Plata the fifth ordinary session of the Federal Health Council (COFESA), together with the governor of the province of Buenos Aires, Daniel Scioli and the Mayor of Mar del Plata, Gustavo Pulti. The minister said that the vaccine will begin to occur in two or three years. "It is what it takes to transfer this technology to the country of high complexity. Meanwhile, we assure the acquisition of the necessary number of doses against seasonal and avian influenza A , to meet the demand of patients in the next winter season, "he said. However, the country already booked about eight million vaccines to fund the World Health Organization (WHO). "In Ecuador down Continued Manzur , Argentina is the first country to develop this vaccine, and integrate the small number of producing countries worldwide, including USA, Switzerland, France, Britain, Italy, Japan, China and India. Members of the convention The laboratories that make up this convention are Novartis Argentina SA (the Swiss group Novartis), Elea and Biogenesis Bago. The Swiss group has plants qualified and certified by national health authorities and WHO, which allows direct access to the vines each year that determines this international organization for global vaccine production. bed pads Manzur anticipated that the village of Garin, in Escobar, one of the places where they will begin manufacturing the vaccine, and that technology will add more plants. The investment will be U.S. 50 million and, according Manzur indirectly generate some 400 jobs for scientists, doctors and other professionals. " Now ............we can say about this flu "MUTO", and its vaccine, which in reality, if we consider the definition of that < " antigens that once inside the body causes an attack response, called antibody.